More recently, the expression of somatostatin receptor subtype 2 (SSTR2) has been demonstrated in canine meningioma, in vivo as in vitro.10 This finding not only is the object of interest for diagnostic purposes in dogs, but it also opens new therapeutic perspectives using somatostatin (SST) analogs. This evidence concerns the gene SSTR2 and meningioma.